|
US3705185A
(en)
|
1969-04-14 |
1972-12-05 |
Minnesota Mining & Mfg |
N-aroyl sulfonamides
|
|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US4485045A
(en)
|
1981-07-06 |
1984-11-27 |
Research Corporation |
Synthetic phosphatidyl cholines useful in forming liposomes
|
|
EP0102324A3
(de)
|
1982-07-29 |
1984-11-07 |
Ciba-Geigy Ag |
Lipide und Tenside in wässriger Phase
|
|
US4544545A
(en)
|
1983-06-20 |
1985-10-01 |
Trustees University Of Massachusetts |
Liposomes containing modified cholesterol for organ targeting
|
|
HUT35524A
(en)
|
1983-08-02 |
1985-07-29 |
Hoechst Ag |
Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
|
|
GB8524157D0
(en)
|
1984-10-19 |
1985-11-06 |
Ici America Inc |
Heterocyclic amides
|
|
US5004697A
(en)
|
1987-08-17 |
1991-04-02 |
Univ. Of Ca |
Cationized antibodies for delivery through the blood-brain barrier
|
|
DK24089D0
(da)
|
1989-01-20 |
1989-01-20 |
Hans Bundgaard |
Novel prodrug derivatives of biologically active agents containing hydroxyl groups or nh-acidic groups
|
|
GB8911854D0
(en)
|
1989-05-23 |
1989-07-12 |
Ici Plc |
Heterocyclic compounds
|
|
US5268164A
(en)
|
1990-04-23 |
1993-12-07 |
Alkermes, Inc. |
Increasing blood-brain barrier permeability with permeabilizer peptides
|
|
US5112596A
(en)
|
1990-04-23 |
1992-05-12 |
Alkermes, Inc. |
Method for increasing blood-brain barrier permeability by administering a bradykinin agonist of blood-brain barrier permeability
|
|
IL101860A0
(en)
|
1991-05-31 |
1992-12-30 |
Ici Plc |
Heterocyclic derivatives
|
|
EP0567997A1
(de)
*
|
1992-04-30 |
1993-11-03 |
Hoechst Aktiengesellschaft |
4- oder 5-(Sulf)imido- und (Sulfon)amidopyridine, sowie ihre Pyridin-N-oxide, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
AU677216B2
(en)
|
1992-07-27 |
1997-04-17 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Targeting of liposomes to the blood-brain barrier
|
|
ES2187518T3
(es)
|
1992-11-23 |
2003-06-16 |
Aventis Pharma Inc |
3-(aminoalquilamino)-1-2-benzisoxazoles sustituidos y compuestos relacionados.
|
|
US5573653A
(en)
|
1994-07-11 |
1996-11-12 |
Sandoz Ltd. |
Electrochemical process for thiocyanating aminobenzene compounds
|
|
GB9514160D0
(en)
*
|
1994-07-25 |
1995-09-13 |
Zeneca Ltd |
Aromatic compounds
|
|
ATE253057T1
(de)
|
1994-08-30 |
2003-11-15 |
Sankyo Co |
Isoxazole
|
|
US5753653A
(en)
|
1995-12-08 |
1998-05-19 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
|
|
GB9828442D0
(en)
*
|
1998-12-24 |
1999-02-17 |
Karobio Ab |
Novel thyroid receptor ligands and method II
|
|
JP4316787B2
(ja)
*
|
2000-01-11 |
2009-08-19 |
壽製薬株式会社 |
エーテル又はアミド誘導体、その製法並びにそれを含有する糖尿病治療剤、
|
|
US6514221B2
(en)
|
2000-07-27 |
2003-02-04 |
Brigham And Women's Hospital, Inc. |
Blood-brain barrier opening
|
|
AU2001286557A1
(en)
*
|
2000-08-23 |
2002-03-04 |
Merck Frosst Canada And Co. |
Method of treating or preventing urinary incontinence using prostanoid ep1 receptor antagonists
|
|
AU2001286930A1
(en)
|
2000-08-30 |
2002-03-13 |
The Board Of Trustees Of The Leland Stanford Junior University |
Glucocorticoid blocking agents for increasing blood-brain barrier permeability
|
|
US7034036B2
(en)
|
2000-10-30 |
2006-04-25 |
Pain Therapeutics, Inc. |
Inhibitors of ABC drug transporters at the blood-brain barrier
|
|
DE10121982B4
(de)
|
2001-05-05 |
2008-01-24 |
Lts Lohmann Therapie-Systeme Ag |
Nanopartikel aus Protein mit gekoppeltem Apolipoprotein E zur Überwindung der Blut-Hirn-Schranke und Verfahren zu ihrer Herstellung
|
|
EP2147679B1
(en)
|
2001-07-25 |
2014-06-25 |
Raptor Pharmaceutical, Inc. |
Compositions for blood-brain barrier transport
|
|
KR100789567B1
(ko)
|
2001-11-06 |
2007-12-28 |
동화약품공업주식회사 |
3-아미도-1,2-벤조이소옥사졸 유도체, 그 염, 제조방법 및 용도
|
|
DE10201550A1
(de)
|
2002-01-17 |
2003-07-31 |
Merck Patent Gmbh |
Phenoxy-Piperidine
|
|
US20030162695A1
(en)
|
2002-02-27 |
2003-08-28 |
Schatzberg Alan F. |
Glucocorticoid blocking agents for increasing blood-brain barrier permeability
|
|
EP1529049B1
(en)
|
2002-08-08 |
2009-11-18 |
Memory Pharmaceuticals Corporation |
Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors
|
|
US7220833B2
(en)
|
2002-12-03 |
2007-05-22 |
Thomas Nelson |
Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier
|
|
US7132425B2
(en)
|
2002-12-12 |
2006-11-07 |
Hoffmann-La Roche Inc. |
5-substituted-six-membered heteroaromatic glucokinase activators
|
|
GT200300283A
(es)
*
|
2002-12-12 |
2004-07-14 |
|
Activadores de glucoquinasa heteroaromaticos de seis miembros 5-sustituidos
|
|
WO2004092145A1
(en)
|
2003-04-15 |
2004-10-28 |
Pfizer Inc. |
Alpha substituted carboxylic acid as ppar modulators
|
|
ZA200601942B
(en)
|
2003-08-08 |
2007-05-30 |
Vertex Pharma |
Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
|
|
KR20060073930A
(ko)
|
2003-08-08 |
2006-06-29 |
버텍스 파마슈티칼스 인코포레이티드 |
통증 치료시 나트륨 또는 칼슘 채널 차단제로서 유용한헤테로아릴아미노설포닐페닐 유도체
|
|
JP2007505142A
(ja)
|
2003-09-10 |
2007-03-08 |
セダーズ−シナイ メディカル センター |
血液脳関門を通過する薬剤のカリウムチャネル媒介性送達
|
|
PT1668002E
(pt)
|
2003-10-03 |
2009-11-25 |
Portola Pharm Inc |
2,4-dioxo-3-quinazolinilarilsulfonilureias
|
|
US7081539B2
(en)
|
2004-03-25 |
2006-07-25 |
Dainippon Sumitomo Pharma Co., Ltd. |
One-pot process for the preparation of 1,2-benzisoxazole-3-methanesulfonamide
|
|
MY134672A
(en)
|
2004-05-20 |
2007-12-31 |
Japan Tobacco Inc |
Stable crystal of 4-oxoquinoline compound
|
|
EP1773792A1
(en)
|
2004-07-30 |
2007-04-18 |
Merck & Co., Inc. |
Indanone potentiators of metabotropic glutamate receptors
|
|
CA2576993C
(en)
|
2004-08-12 |
2013-09-24 |
Amgen Inc. |
Bisaryl-sulfonamides
|
|
US7205296B2
(en)
|
2004-09-29 |
2007-04-17 |
Portola Pharmaceuticals, Inc. |
Substituted 2H-1,3-benzoxazin-4(3H)-ones
|
|
JP2008189549A
(ja)
|
2005-05-12 |
2008-08-21 |
Astellas Pharma Inc |
カルボン酸誘導体またはその塩
|
|
DE102005038947A1
(de)
|
2005-05-18 |
2006-11-30 |
Grünenthal GmbH |
Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln
|
|
US7632837B2
(en)
|
2005-06-17 |
2009-12-15 |
Bristol-Myers Squibb Company |
Bicyclic heterocycles as cannabinoid-1 receptor modulators
|
|
US7915410B2
(en)
|
2005-09-09 |
2011-03-29 |
Bristol-Myers Squibb Company |
Acyclic IKur inhibitors
|
|
ES2320042T3
(es)
|
2005-10-19 |
2009-05-18 |
F. Hoffmann-La Roche Ag |
Inhibidores de transcriptasa reversa con nucleosidos de n-fenil fenilacetamida.
|
|
BRPI0620532A2
(pt)
|
2005-11-23 |
2011-11-16 |
Ligand Pharm Inc |
compostos e métodos para modular a atividade de trombopoietina
|
|
AR058296A1
(es)
|
2005-12-09 |
2008-01-30 |
Kalypsys Inc |
Inhibidores de histona desacetilasa y composicion farmaceutica
|
|
KR20080109918A
(ko)
*
|
2006-04-11 |
2008-12-17 |
버텍스 파마슈티칼스 인코포레이티드 |
전압 개폐 나트륨 채널의 억제제로서 유용한 조성물
|
|
AU2007307031B2
(en)
|
2006-10-11 |
2011-11-24 |
Amgen Inc. |
Imidazo- and triazolo-pyridine compounds and methods of use therof
|
|
WO2008094575A2
(en)
|
2007-01-30 |
2008-08-07 |
Biogen Idec Ma Inc. |
1-h-pyrazolo(3,4b)pyrimidine derivatives and their use as modulators of mitotic kinases
|
|
AR065194A1
(es)
*
|
2007-02-05 |
2009-05-20 |
Xenon Pharmaceuticals Inc |
Compuestos de piridopirimidinona de utilidad en el tratamiento de enfermedades o condiciones patologicas mediadas por los canales de sodio
|
|
JP5361857B2
(ja)
|
2007-03-23 |
2013-12-04 |
ファイザー・リミテッド |
イオンチャネルの阻害剤
|
|
JP2010528035A
(ja)
|
2007-05-25 |
2010-08-19 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
イオンチャネル調節物質およびその使用
|
|
TW200911245A
(en)
|
2007-06-07 |
2009-03-16 |
Astellas Pharma Inc |
Pyridone derivatives
|
|
US20090012103A1
(en)
|
2007-07-05 |
2009-01-08 |
Matthew Abelman |
Substituted heterocyclic compounds
|
|
WO2009010784A1
(en)
|
2007-07-13 |
2009-01-22 |
Astrazeneca Ab |
New compounds 955
|
|
WO2009012242A2
(en)
|
2007-07-13 |
2009-01-22 |
Icagen, Inc. |
Sodium channel inhibitors
|
|
WO2009022730A1
(ja)
|
2007-08-10 |
2009-02-19 |
Nippon Chemiphar Co., Ltd. |
Ｐ２ｘ４受容体拮抗剤
|
|
GB0720390D0
(en)
|
2007-10-18 |
2007-11-28 |
Prosidion Ltd |
G-Protein coupled receptor agonists
|
|
US8642660B2
(en)
|
2007-12-21 |
2014-02-04 |
The University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
SI2565191T1
(sl)
*
|
2008-05-14 |
2014-12-31 |
Astellas Pharma Inc. |
Derivati 4-(indol-7-ilkarbonilaminometil)cikloheksan karboksilne kisline kot EP4 receptorski antagonisti, uporabni za zdravljenje kronične ledvične odpovedi ali diabetične nefropatije
|
|
MX2010014232A
(es)
|
2008-06-23 |
2011-03-25 |
Astellas Pharma Inc |
Compuesto de sulfamida o sal del mismo.
|
|
WO2010022055A2
(en)
|
2008-08-20 |
2010-02-25 |
Amgen Inc. |
Inhibitors of voltage-gated sodium channels
|
|
EA020460B1
(ru)
|
2009-01-12 |
2014-11-28 |
Пфайзер Лимитед |
Производные сульфонамида
|
|
ME02847B
(me)
|
2009-07-27 |
2018-01-20 |
Gilead Sciences Inc |
Fuzionisana heterociklična jedinjenja kao modulatori jonskih kanala
|
|
WO2011016234A1
(en)
|
2009-08-04 |
2011-02-10 |
Raqualia Pharma Inc. |
Picolinamide derivatives as ttx-s blockers
|
|
RU2563639C2
(ru)
*
|
2009-09-25 |
2015-09-20 |
Астеллас Фарма Инк. |
Замещенные соединения амида
|
|
WO2011059042A1
(ja)
|
2009-11-12 |
2011-05-19 |
武田薬品工業株式会社 |
芳香環化合物
|
|
WO2011063001A1
(en)
|
2009-11-18 |
2011-05-26 |
Concert Pharmaceuticals, Inc. |
Niacin prodrugs and deuterated versions thereof
|
|
TW201139406A
(en)
|
2010-01-14 |
2011-11-16 |
Glaxo Group Ltd |
Voltage-gated sodium channel blockers
|
|
WO2011100433A1
(en)
|
2010-02-12 |
2011-08-18 |
N30 Pharmaceuticals, Llc |
Novel s-nitrosoglutathione reductase inhibitors
|
|
WO2011153588A1
(en)
|
2010-06-10 |
2011-12-15 |
Biota Scientific Management Pty Ltd |
Viral polymerase inhibitors
|
|
US20120004714A1
(en)
|
2010-06-30 |
2012-01-05 |
Ryan Kleve |
Lead having coil electrode with preferential bending region
|
|
WO2012004664A2
(en)
|
2010-07-07 |
2012-01-12 |
Purdue Pharma L.P. |
Analogs of sodium channel peptide toxin
|
|
ES2533065T3
(es)
|
2010-07-09 |
2015-04-07 |
Pfizer Limited |
Bencenosulfonamidas útiles como inhibidores de los canales de sodio
|
|
US9096558B2
(en)
|
2010-07-09 |
2015-08-04 |
Pfizer Limited |
N-sulfonylbenzamide compounds
|
|
ES2532356T3
(es)
|
2010-07-09 |
2015-03-26 |
Pfizer Limited |
N-sulfonilbenzamidas como inhibidores de los canales de sodio dependientes de voltaje
|
|
CA2804351A1
(en)
*
|
2010-07-12 |
2012-01-19 |
Pfizer Limited |
Chemical compounds
|
|
US9102621B2
(en)
|
2010-07-12 |
2015-08-11 |
Pfizer Limited |
Acyl sulfonamide compounds
|
|
CA2804877A1
(en)
|
2010-07-12 |
2012-01-19 |
Pfizer Limited |
Sulfonamide derivatives as nav1.7 inhibitors for the treatment of pain
|
|
WO2012007868A2
(en)
*
|
2010-07-12 |
2012-01-19 |
Pfizer Limited |
Chemical compounds
|
|
ES2525581T3
(es)
|
2010-07-12 |
2014-12-26 |
Pfizer Limited |
Derivados de N-sulfonilbenzamida útiles como inhibidores del canal de sodio dependiente de voltaje
|
|
WO2012007836A1
(en)
|
2010-07-16 |
2012-01-19 |
Purdue Pharma .Lp. |
Pyridine compounds as sodium channel blockers
|
|
SI2616465T1
(sl)
|
2010-09-13 |
2016-02-29 |
Novartis Ag |
Triazin-oksadiazoli
|
|
WO2012039657A1
(en)
|
2010-09-22 |
2012-03-29 |
Astrazeneca Ab |
Novel chromane compound for the treatment of pain disorders
|
|
CA2822789A1
(en)
|
2010-12-22 |
2012-06-28 |
Purdue Pharma L.P. |
Substituted pyridines as sodium channel blockers
|
|
WO2012095781A1
(en)
|
2011-01-13 |
2012-07-19 |
Pfizer Limited |
Indazole derivatives as sodium channel inhibitors
|
|
TWI520964B
(zh)
|
2011-02-02 |
2016-02-11 |
維泰克斯製藥公司 |
作為離子通道調節劑之吡咯并吡－螺環哌啶醯胺
|
|
US9079902B2
(en)
|
2011-08-17 |
2015-07-14 |
Amgen Inc. |
Heteroaryl sodium channel inhibitors
|
|
US20140235676A1
(en)
|
2011-10-13 |
2014-08-21 |
Case Western Reserve University |
Rxr agonist compounds and methods
|
|
JP2014532660A
(ja)
|
2011-10-28 |
2014-12-08 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
電位作動型ナトリウムチャネルにおける選択活性を有するベンゾオキサゾリノン化合物
|
|
EP2773641B1
(en)
|
2011-10-31 |
2017-09-27 |
Xenon Pharmaceuticals Inc. |
Biaryl ether sulfonamides and their use as therapeutic agents
|
|
WO2013064983A1
(en)
|
2011-10-31 |
2013-05-10 |
Xenon Pharmaceuticals Inc. |
Benzenesulfonamide compounds and their use as therapeutic agents
|
|
WO2013072758A1
(en)
|
2011-11-15 |
2013-05-23 |
Purdue Pharma L.P. |
Pyrimidine diol amides as sodium channel blockers
|
|
WO2013086229A1
(en)
|
2011-12-07 |
2013-06-13 |
Amgen Inc. |
Bicyclic aryl and heteroaryl sodium channel inhibitors
|
|
WO2013088315A1
(en)
|
2011-12-15 |
2013-06-20 |
Pfizer Limited |
Sulfonamide derivatives
|
|
CA2860553C
(en)
|
2012-01-04 |
2016-08-23 |
Pfizer Limited |
N-aminosulfonyl benzamides
|
|
JP2015083542A
(ja)
|
2012-02-08 |
2015-04-30 |
大日本住友製薬株式会社 |
３位置換プロリン誘導体
|
|
US8889741B2
(en)
|
2012-02-09 |
2014-11-18 |
Daiichi Sankyo Company, Limited |
Cycloalkane derivatives
|
|
WO2013122897A1
(en)
|
2012-02-13 |
2013-08-22 |
Amgen Inc. |
Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors
|
|
US9051311B2
(en)
|
2012-03-09 |
2015-06-09 |
Amgen Inc. |
Sulfamide sodium channel inhibitors
|
|
WO2013146969A1
(ja)
|
2012-03-29 |
2013-10-03 |
第一三共株式会社 |
新規二置換シクロヘキサン誘導体
|
|
SG11201408284VA
(en)
|
2012-05-22 |
2015-02-27 |
Xenon Pharmaceuticals Inc |
N-substituted benzamides and their use in the treatment of pain
|
|
US10071957B2
(en)
|
2012-07-06 |
2018-09-11 |
Genentech, Inc. |
N-substituted benzamides and methods of use thereof
|
|
AU2013291098A1
(en)
|
2012-07-19 |
2015-02-05 |
Sumitomo Dainippon Pharma Co., Ltd. |
1-(cycloalkyl-carbonyl)proline derivative
|
|
EP2911668A4
(en)
|
2012-10-26 |
2016-07-20 |
Merck Sharp & Dohme |
BENZOXAZOLINONE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-CONTROLLED SODIUM CHANNELS
|
|
BR112015008987A2
(pt)
|
2012-10-26 |
2017-07-04 |
Merck Sharp & Dohme |
composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de uma composição farmacêutica
|
|
US9714252B2
(en)
|
2012-12-20 |
2017-07-25 |
Purdue Pharma L.P. |
Cyclic sulfonamides as sodium channel blockers
|
|
SMT201700256T1
(it)
|
2013-01-31 |
2017-09-07 |
Vertex Pharma |
Piridone ammidi come modulatori di canali del sodio
|
|
US20140296266A1
(en)
|
2013-03-01 |
2014-10-02 |
Gilead Sciences, Inc. |
Therapeutic compounds
|
|
RU2015143906A
(ru)
|
2013-03-14 |
2017-04-18 |
Дженентек, Инк. |
Замещенные триазолопиридины и способы их применения
|
|
US9493429B2
(en)
|
2013-03-15 |
2016-11-15 |
Genentech, Inc. |
Substituted benzoxazoles and methods of use thereof
|
|
CA2900604A1
(en)
|
2013-03-15 |
2014-09-25 |
Chromocell Corporation |
Sodium channel modulators for the treatment of pain
|
|
WO2015051043A1
(en)
|
2013-10-01 |
2015-04-09 |
Amgen Inc. |
Biaryl acyl-sulfonamide compounds as sodium channel inhibitors
|
|
AU2014356967A1
(en)
|
2013-11-27 |
2016-07-07 |
Genentech, Inc. |
Substituted benzamides and methods of use thereof
|